REDONDO BEACH, CA / ACCESSWIRE / July 21, 2015 / Diabetes affects approximately 387 million people worldwide and that figure is expected to soar to nearly 600 million by 2035, according to the International Diabetes Federation. At the same time,…
LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) an early development stage company focused on the discovery, development and commercialization of therapeutic devices for patients with diseases such as diabetes is pleased to update the timeline…
— Company study aims to determine efficacy of diabetes treatment Las Vegas, Nevada, July 7, 2015, Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) is pleased to announce that efforts are underway to commence clinical trials of its…